Description
Amcinonide is a corticosteroid that is known to be effective against psoriasis and eczematous dermatitis.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Amcinonide is a corticosteroid that is known to be effective against psoriasis and eczematous dermatitis.
| Cas No. | 51022-69-6 |
|---|---|
| Purity | ≥98% |
| Formula | C28H35FO7 |
| Formula Wt. | 502.6 |
| Chemical Name | [2-[(1S,2S,4R,8S,9S,11S,12R,13S)-12-fluoro-11-hydroxy-9,13-dimethyl-16-oxospiro[5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-diene-6,1'-cyclopentane]-8-yl]-2-oxoethyl] acetate |
| IUPAC Name | [2-[(1S,2S,4R,8S,9S,11S,12R,13S)-12-fluoro-11-hydroxy-9,13-dimethyl-16-oxospiro[5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-diene-6,1'-cyclopentane]-8-yl]-2-oxoethyl] acetate |
| Synonym | Cyclocort; Amcinonidum; Triamcinolonacetatcyclopentanonid |
| Solubility | 100mg/mL in DMSO 25mg/mL in EtOH |
| Appearance | White powder |
| Store Temp | Ambient |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Cornell R. Comparison of amcinonide ointment 0.1 percent twice daily and fluocinolide ointment 0.05 percent three times daily in the treatment of psoriasis. Cutis. 1983 May;31(5):566-569. PMID: 6851655.
Rosenberg E. Management of eczematous dermatitis with amcinonide or betamethasone valerate. A double-blind comparative study. Cutis. 1979 Dec;24(6):642-645. PMID: 391500.
Endogenous peptide hormone fragment, involved i...
Potential p53 activator or SIRT2 inhibitor.
Diterpene cafestol derivative found in coffee b...
Polymethoxylated flavone found in citrus fruits...
Glycopeptide, induces DNA strand breaks.
Pyrrolidone; NMDA and mGluR5 agonist, N-type an...
Citalopram analog
BRD inhibitor.
Acyclic nucleotide (adenosine) analog, adefovir...
Endogenous heptapeptide; P2X3 and N-formylpepti...
Kavalactone originally found in Piper methystic...
Nucleoside (adenosine) analog found in Tethyra ...
Synthetic steroid hormone, estrogen analog, use...
nNOS inhibitor.
Triazolothienodiazepine, JQ-1 derivative; BRD i...
σ2 agonist.
β2-adrenergic agonist.
AurKA/B inhibitor.
Somewhat selective in inhibiting COX-2 over COX...
NO donor; annexin A2 inhibitor.